Buy BioSpecifics Technologies Stock | BSTC Stock Price & Latest News | Public.com
BSTC

BioSpecifics Technologies

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View BioSpecifics Technologies (BSTC) stock trends here

    About BSTC

    BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s co...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.12
    0.75
    0.37
    0
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $1.12

    Actual EPS
    Q1 2021

    Stats

    Market Cap$650,24M
    Volume
    Price-to-Earnings Ratio37.55
    Dividend Rate
    Dividend Yield
    1 Year High$89.15
    1 Year Low$42.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app